Premarket Biotech Digest – AMGN Announces Positive Results, FOLD Completes Analysis Plan, JNJ Files Lawsuit
May 22, 2017 at 10:41 AM EDT
Amgen Inc. announced that it has received positive results from a Phase 3 clinical trial. AstraZeneca announced selling the European rights to its aging beta-blocker heart drug Seloken to Italian company Recordati.
